Filing Flows › Bio-Techne (TECH) › Q2 FY26
Bio-Techne (TECH) Q2 FY26 earnings results (second quarter fiscal 2026)
10-Q filed Feb 4, 2026
Bio-Techne (TECH) reported revenue of $296M for the second quarter fiscal 2026 (Q2 FY26), -0.4% from a year earlier and +3% from the quarter before. Operating margin was 18.4%, net earnings $38.0M (12.8% of revenue).
Bio-Techne, Q2 FY26: revenue $296M (-0.4% year over year), operating margin 18.4%, net earnings $38.0M, operating cash flow $82.4M. The chart follows the revenue to costs, profit and cash.
| Q2 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $296M | +3% | -0.4% |
| Gross profit | $191M | +2% | -1% |
| Operating profit | $54.5M | +14% | +15% |
| Net earnings | $38.0M | -0.5% | +9% |
| Operating cash flow | $82.4M | +199% | -2% |
| Free cash flow | $76.5M | +244% | -1% |
What changed
Revenue was $295.9M in Q2 FY26, roughly flat year over year and up 3% from the previous quarter. Consumables was the largest line at 80% of revenue. Services lost $5.0M year over year (down 18%), 436% of the total change.
Gross margin was 64.6%, down 0.6 points from a year earlier. Operating profit was $54.5M, a 18.4% margin (up 2.4 points year over year). Operating expenses fell 7% while revenue was flat. Net earnings were $38.0M, up 9% year over year. The effective tax rate was 25.2%.
Operating cash flow was $82.4M (down 2% year over year), 217% of net earnings. Non-cash charges added back $24.7M of depreciation and amortization and $14.0M of share-based compensation. Working capital and other items added $5.7M. Capital expenditures of $5.9M left free cash flow of $76.5M.
Questions
What was Bio-Techne's revenue in the second quarter fiscal 2026?
Bio-Techne (TECH) reported revenue of $296M for the second quarter fiscal 2026 (Q2 FY26), -0.4% from a year earlier and +3% from the quarter before.
Was Bio-Techne profitable in the second quarter fiscal 2026?
Operating profit was $54.5M (18.4% of revenue) and net earnings $38.0M.
Source: Bio-Techne 10-Q on SEC EDGAR.